AllianceBernstein’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
130,830
+3,060
| +2% | +$86.9K | ﹤0.01% | 1617 |
|
|
2025
Q1 | $3.77M | Hold |
127,770
| – | – | ﹤0.01% | 1564 |
|
|
2024
Q4 | $3.72M | Sell |
127,770
-42,914
| -25% | -$1.25M | ﹤0.01% | 1633 |
|
|
2024
Q3 | $7.84M | Sell |
170,684
-45,544
| -21% | -$2.09M | ﹤0.01% | 1319 |
|
|
2024
Q2 | $8.83M | Sell |
216,228
-112,298
| -34% | -$4.59M | ﹤0.01% | 1236 |
|
|
2024
Q1 | $8.38M | Sell |
328,526
-46,150
| -12% | -$1.18M | ﹤0.01% | 1240 |
|
|
2023
Q4 | $3.39M | Sell |
374,676
-152,939
| -29% | -$1.38M | ﹤0.01% | 1666 |
|
|
2023
Q3 | $3.37M | Buy |
527,615
+362,215
| +219% | +$2.31M | ﹤0.01% | 1592 |
|
|
2023
Q2 | $1.83M | Buy |
165,400
+119,900
| +264% | +$1.33M | ﹤0.01% | 1947 |
|
|
2023
Q1 | $698K | Sell |
45,500
-162,560
| -78% | -$2.5M | ﹤0.01% | 2399 |
|
|
2022
Q4 | $4.62M | Buy |
208,060
+88,694
| +74% | +$1.97M | ﹤0.01% | 1470 |
|
|
2022
Q3 | $1.95M | Sell |
119,366
-152,923
| -56% | -$2.5M | ﹤0.01% | 1898 |
|
|
2022
Q2 | $3.96M | Buy |
272,289
+130,280
| +92% | +$1.89M | ﹤0.01% | 1563 |
|
|
2022
Q1 | $2.62M | Sell |
142,009
-5,307
| -4% | -$98K | ﹤0.01% | 1926 |
|
|
2021
Q4 | $3.5M | Buy |
+147,316
| New | +$3.5M | ﹤0.01% | 1801 |
|
|
2021
Q3 | – | Sell |
-10,700
| Closed | -$264K | – | 3319 |
|
|
2021
Q2 | $264K | Buy |
+10,700
| New | +$264K | ﹤0.01% | 3049 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$283K | – | 3195 |
|
|
2020
Q2 | $283K | Buy |
+10,000
| New | +$283K | ﹤0.01% | 2893 |
|